Publications by authors named "Imad Al-Dakkak"

Claim this Profile
C
Clinical and genetic characteristics of patients diagnosed with atypical hemolytic uremic syndrome (aHUS): epidemiological data from the Belgian cohort of the Global aHUS Registry.
Annick Massart, Laurent Weekers, Kathleen J Claes, Tess Van Meerhaeghe, Evelien Snauwaert, Imad Al-Dakkak

J Nephrol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and Safety of Switching to Ravulizumab From Eculizumab in Kidney Transplant Recipients With Atypical Hemolytic Uremic Syndrome: A Global aHUS Registry Analysis.
Anja Gaeckler, Imad Al-Dakkak, Nuria Saval, Hans Herman Dieperink, Margriet Eygenraam

Clin Transplant· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demographics and baseline disease characteristics of UK patients within the global aHUS registry.
Rodney D Gilbert, Imad Al-Dakkak, Clare Boothe, Timothy E Cobb, Daniel P Gale

BMC Nephrol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global aHUS Registry Analysis of Patients Switching to Ravulizumab From Eculizumab.
Franz Schaefer, Imad Al-Dakkak, Katerina Anokhina, David Cohen, Larry A Greenbaum

Kidney Int Rep· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of patients with aHUS and associated triggers or clinical conditions: A Global aHUS Registry analysis.
Christoph Licht, Imad Al-Dakkak, Katerina Anokhina, Nicole Isbel, Véronique Frémeaux-Bacchi

Nephrology (Carlton)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atypical Hemolytic Uremic Syndrome Treated With Ravulizumab or Eculizumab: A Claims-Based Evaluation of Health Care Resource Utilization and Clinical Outcomes in the United States.
Yan Wang, Imad Al-Dakkak, Katherine Garlo, Moh-Lim Ong, Ioannis Tomazos

Kidney Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and outcomes of a patient population with atypical hemolytic uremic syndrome and malignant hypertension: analysis from the Global aHUS registry.
Jean-Michel Halimi, Imad Al-Dakkak, Katerina Anokhina, Gianluigi Ardissino, Christoph Licht

J Nephrol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancy in Women with Atypical Hemolytic Uremic Syndrome.
Eric Rondeau, Gianluigi Ardissino, Marie-Pierre Caby-Tosi, Imad Al-Dakkak, Fadi Fakhouri

Nephron· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis.
Fadi Fakhouri, Marie Scully, Gianluigi Ardissino, Imad Al-Dakkak, Benjamin Miller

J Nephrol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Effectiveness of Apixaban Additional Risk Minimisation Measures Using Surveys in Europe.
Steve Mayall, Randip Kahlon, Imad Al-Dakkak, Sophie W Shen

Pharmaceut Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional Assessment of Fatigue and Other Patient-Reported Outcomes in Patients Enrolled in the Global aHUS Registry.
Larry A Greenbaum, Christoph Licht, Vasileios Nikolaou, Imad Al-Dakkak, Janet Green

Kidney Int Rep· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characteristics and Outcome of Canadian Patients Diagnosed With Atypical Hemolytic Uremic Syndrome.
Anne-Laure Lapeyraque, Martin Bitzan, Imad Al-Dakkak, Mira Francis, Shih-Han S Huang

Can J Kidney Health Dis· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eculizumab Safety: Five-Year Experience From the Global Atypical Hemolytic Uremic Syndrome Registry.
Eric Rondeau, Spero R Cataland, Imad Al-Dakkak, Benjamin Miller, Nicholas J A Webb

Kidney Int Rep· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness Evaluation of Additional Risk Minimization Measures for Adolescent Use of Aripiprazole in the European Union: Results from a Post-Authorization Safety Study.
Wally Landsberg, Imad Al-Dakkak, Antonia Coppin-Renz, Uli Geis, Timothy Peters-Strickland

Drug Saf· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Which Metrics Are Appropriate to Describe the Value of New Cancer Therapies?
Peter Johnson, Wolfgang Greiner, Imad Al-Dakkak, Samuel Wagner

Biomed Res Int· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of specific HIV treatment-related adverse events on adherence to antiretroviral therapy: a systematic review and meta-analysis.
Imad Al-Dakkak, Seema Patel, Eilish McCann, Abhijit Gadkari, Girish Prajapati

AIDS Care· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maté intake and risk of oral and pharyngeal cancers.
Imad Al-Dakkak, Andrew Ternouth

Evid Based Dent· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Socio-economic status and upper aerodigestive tract cancer.
Imad Al-Dakkak, Maawan Khadra

Evid Based Dent· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between cancer treatments and oral diseases.
Imad Al-Dakkak

Evid Based Dent· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tea, coffee and oral cancer risk.
Imad Al-Dakkak

Evid Based Dent· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Public awareness of oral cancer and associated risk factors is low.
Imad Al-Dakkak

Evid Based Dent· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral dysplasia and risk of progression to cancer.
Imad Al-Dakkak

Evid Based Dent· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Socioeconomic status and head and neck cancer.
Imad Al-Dakkak

Evid Based Dent· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic delay broadly associated with more advanced stage oral cancer.
Imad Al-Dakkak

Evid Based Dent· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis